Functional significance of Argonaute 2 proteoforms in the plant antiviral immune response

Argonaute 2 蛋白型在植物抗病毒免疫反应中的功能意义

基本信息

项目摘要

RNA silencing or RNA interference (RNAi) is a central component of the immune response of plants against viral infections. First, Dicer-like enzymes process double-stranded elements of viral RNAs, i.e., viral genomes, - replicative intermediates and/or – mRNAs, into small interfering RNAs, siRNAs. As part of RNA-induced silencing complexes (RISC), Argonaute (AGO) endonucleases then incorporate single siRNA strands, and these direct RISC to target RNAs via complementary base pairing. The target RNAs mostly correspond to the cognate RNAs from which the siRNAs were earlier generated. AGO/RISC that contain virus-derived ‘vsiRNAs’ then either degrade viral target RNAs by endonucleolytic cleavage or inhibit their translation. Importantly, in virus infected cells, RNAi affects not only viral but also cellular gene expression. Recently, the latter was found to occur primarily through the generation of a new class of siRNAs that arise from cellular mRNAs and are termed ‘virus-activated’ ‘vasiRNAs’. Interestingly, observations by others and us showed that infections with different types of viruses in Brassicaceae induce the formation of vasiRNAs that down-regulate the expression of the same group of genes, including several that play important roles in stress response and photosynthesis. As an important part of the immune response, vasiRNAs thus appear to inhibit viral replication via modulation of the stress response or by depletion of energy resources. Antiviral RNAi essentially involves 21 nt as well as 22 nt long vsiRNAs and vasiRNAs. However, especially for 22 nt siRNAs, the modes of activity are still unclear. The same is true for the AGO2 protein, which, of the at least 10 AGO proteins identified in the model plant Arabidopsis thaliana (At) has recently come into focus as a crucial component of both vsiRNA- and vasiRNA-mediated antiviral silencing. In this context, it was unexpectedly found that AGO2, in contrast to the also antivirally acting AGO1, is subject to strong selection pressure to diversify. Most interestingly, we recently observed that proteoforms of AGO2 in At, i.e. variants of the protein caused by single nucleotide polymorphisms (SNPs), show marked differences in their silencing activity when associated with 22 nt siRNAs. The central hypothesis arising from this is that AGO2 proteoforms play an essential role in plant adaptation to viral infections through differential activity of 22 nt siRNAs. This adaptation could occur at the level of viral gene expression and replication via differential activity of 22 nt vsiRNAs and/or at the level of host gene expression via differential activity of 22 nt vasiRNAs. Our proposed project aims at proving this hypothesis by (i) identifying the molecular determinants, which mediate the differential activities of AGO2 proteoforms with 22 nt siRNAs and by (ii) characterizing the antiviral activity of AGO2 SNP proteoforms in vsiRNA- and vasiRNA-mediated RNA silencing in plant.
RNA沉默或RNA干扰(RNAi)是植物抗病毒感染免疫反应的核心组成部分。首先,Dicer样酶加工病毒RNA的双链元件,即,病毒基因组、-复制中间体和/或-mRNA,转化为小干扰RNA,siRNA。作为RNA诱导的沉默复合物(RISC)的一部分,Argonaute(AGO)核酸内切酶然后掺入单个siRNA链,并且这些通过互补碱基配对将RISC引导至靶RNA。靶RNA主要对应于早期产生siRNA的同源RNA。含有病毒衍生的“vsiRNA”的AGO/RISC然后通过内切核酸裂解降解病毒靶RNA或抑制它们的翻译。重要的是,在病毒感染的细胞中,RNAi不仅影响病毒,而且影响细胞基因表达。最近,发现后者主要通过产生一类新的siRNA而发生,所述siRNA产生自细胞mRNA并且被称为“病毒激活的”“vasiRNA”。有趣的是,其他人和我们的观察表明,在菊科中感染不同类型的病毒会诱导vasiRNA的形成,这些vasiRNA下调同一组基因的表达,包括在胁迫反应和光合作用中发挥重要作用的几个基因。作为免疫应答的重要部分,vasiRNA因此似乎通过调节应激应答或通过消耗能量资源来抑制病毒复制。抗病毒RNAi基本上涉及21 nt以及22 nt长的vsiRNA和vasiRNA。然而,特别是对于22 nt siRNA,其活性模式仍不清楚。AGO 2蛋白也是如此,在模式植物拟南芥(At)中鉴定的至少10种AGO蛋白中,AGO 2蛋白最近成为vsiRNA和vasiRNA介导的抗病毒沉默的关键组分。在这种情况下,出乎意料地发现,AGO 2,与同样具有抗病毒作用的AGO 1相反,受到强大的选择压力以多样化。最有趣的是,我们最近观察到,AGO 2在At中的蛋白质形式,即由单核苷酸多态性(SNP)引起的蛋白质变体,当与22 nt siRNA相关联时,其沉默活性显示出显著差异。由此产生的中心假设是AGO 2蛋白形式通过22 nt siRNA的差异活性在植物适应病毒感染中发挥重要作用。这种适应可能通过22 nt vsiRNA的差异活性在病毒基因表达和复制水平上发生,和/或通过22 nt vsiRNA的差异活性在宿主基因表达水平上发生。我们提出的项目旨在证明这一假设,通过(i)确定分子决定簇,介导AGO 2蛋白质与22 nt siRNA的差异活性和(ii)表征AGO 2 SNP蛋白质在vsiRNA和vasiRNA介导的RNA沉默中的抗病毒活性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Sven-Erik Behrens其他文献

Professor Dr. Sven-Erik Behrens的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Sven-Erik Behrens', 18)}}的其他基金

Functional characterization of cellular RNA-binding proteins that support Flavivirus replication
支持黄病毒复制的细胞 RNA 结合蛋白的功能表征
  • 批准号:
    319589351
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Application of TAL effectors to control gene expression in human cells
TAL效应器在控制人体细胞基因表达中的应用
  • 批准号:
    215015307
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Effect of viral infections on the activity of cellular RNAs
病毒感染对细胞 RNA 活性的影响
  • 批准号:
    47325587
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
    Research Units
Characterization of host proteins that participate in the replication of hepatitis C virus (HCV)
参与丙型肝炎病毒 (HCV) 复制的宿主蛋白的表征
  • 批准号:
    32153108
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Efficient small nucleic acids to combat human respiratory viruses
高效小核酸对抗人类呼吸道病毒
  • 批准号:
    462028519
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Uncovering the evolutionary history and significance of Fibonacci spirals in vascular plants
揭示维管植物中斐波那契螺旋的进化历史和意义
  • 批准号:
    EP/Y037138/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
The mechanistic basis of slow-fast phenotypic diversity and its functional and evolutionary significance in social groups
慢-快表型多样性的机制基础及其在社会群体中的功能和进化意义
  • 批准号:
    2241230
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
CAREER: Determining the mechanism and significance of microplastic pollution impacts on soil hydrology
职业:确定微塑料污染对土壤水文影响的机制和意义
  • 批准号:
    2340588
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Assessing the paleoenvironmental and geobiological significance of carbonates from the Eocene-Oligocene boundary of the White River Group
评估白河群始新世-渐新世边界碳酸盐的古环境和地球生物学意义
  • 批准号:
    2311532
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The significance of new onset anxiety on health outcomes among women with cardiovascular disease: A Canadian Longitudinal Study of Aging cohort study
新发焦虑对患有心血管疾病的女性健康结果的重要性:加拿大老龄化纵向研究队列研究
  • 批准号:
    491767
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Research on the significance of sleep interventions for prevention of cardiovascular diseases in the elderly and middle-aged population
睡眠干预对中老年心血管疾病预防的意义研究
  • 批准号:
    23K09723
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular basis and physiological significance of O-mannosyl glycans in mammals
哺乳动物中O-甘露糖基聚糖的分子基础和生理意义
  • 批准号:
    23H02637
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of clinicopathological significance of Siglec1 in Graves' disease and clinical application of Siglec1
阐明Siglec1在格雷夫斯病中的临床病理意义及其临床应用
  • 批准号:
    23K08015
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gametophytic selfing of ferns: identification in wild populations and its evolutionary significance
蕨类植物配子体自交:野生种群的鉴定及其进化意义
  • 批准号:
    23K05901
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tailored monitoring of patients with monoclonal gammopathy to improve early detection of myeloma and monoclonal gammopathy of clinical significance
对单克隆丙种球蛋白病患者进行定制监测,以提高骨髓瘤和单克隆丙种球蛋白病的早期发现,具有临床意义
  • 批准号:
    MR/V037439/2
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了